Stock Analysis tagged as

Sector - Healthcare and Social Assistance

  • Showing 101-146 of 146 items
  • <<
  • 1
  • 2
  1. The 3 Highest Yielding Pharma Stocks

  2. MELA Gets A Surprising "Yes"

  3. Endo And Forest – Dumpster-Diving In Pharma

  4. R&D The Future For Life Sciences Equipment Firms

  5. When Times Are Tough, Should Investors Go Swiss?

  6. Medtronic's Healthy Growth Outlook

  7. Are Buybacks A Bad Sign?

  8. Betting On Healthcare's Growth Engine

  9. BD Healthy, But No Great Bargain

  10. CVS Still Needs to Prove Itself

  11. The Perpetual Boston Scientific Turnaround Story

  12. Teva And Mylan Show Some Value Remains In Generics

  13. Covidien's Image Starting To Change

  14. Top Dividend Stocks Owned By The Pros

  15. Top Healthcare Dividend Stocks

  16. Should Investors Circle Back To Cubist?

  17. Three Safe Sectors For The Summer

  18. Affymetrix's Downward Spiral Continues

  19. Should Biotech Investors Go Where Institutions Won't?

  20. Immucor Passes Its Last Test

  21. The Best IPOs From The First Half

  22. Top Drug Stocks

  23. Investing For Growth And Value

  24. Pleasure And Pain For Pfizer

  25. Johnson & Johnson Surrenders In Stents

  26. Lipitor: Pfizer's Loss Is Watson's Gain

  27. Should Investors Worry If Gen-Probe Doesn't Sell Out?

  28. 3 Reasons To Own Moog Inc.

  29. A Dull ASCO And The Usual Sell-Off

  30. Arena's New Data Doesn't Change Obesity Pill Outlook

  31. Medtronic Still Muddling Through

  32. Will Nestle Succeed Where Others Have Failed?

  33. Mergers In Orthopedics Could Heat Up Stocks

  34. 7 Dividend Stocks With Big Payouts

  35. Teva And Cephalon Solve Each Other's Problems

  36. Hologic Holding The Line

  37. Novo Nordisk Still One Of The Best Around

  38. Illumina Lights Up Again

  39. Can St. Jude Live Up To Newfound Expectations?

  40. J&J Beats Analyst Expections, But Not Its Rivals

  41. Despite The Noise, Abbott Still A Value

  42. GNC's Solid IPO

  43. Consolidation And Healthcare REITs

  44. Danaher Hopes To Revive Beckman Coulter

  45. Novartis Building Itself Into A One-Stop Shop

  46. MannKind And The FDA - Here We Go Again

  • Showing 101-146 of 146 items
  • <<
  • 1
  • 2
Trading Center